XK related protein 6, abbreviated as XKRX6 or XKR6, is a member of the XK family of proteins, characterized by the presence of a conserved sequence motif known as the XK domain. This family is involved in various cellular processes, including transport across membranes, cell signaling, and apoptosis. The function of XKR6, however, has not been as extensively characterized as other family members.The gene that encodes XKR6 is expressed in multiple tissues, suggesting a broad role in human physiology. Given the functional diversity of the XK family, XKR6 may be involved in similar processes such as transmembrane transport of solutes or involvement in signal transduction pathways that mediate cell survival, proliferation, or cell death.
Structurally, proteins in the XK family typically span the membrane multiple times, indicating that XKR6 likely has multiple transmembrane domains. This structure allows such proteins to interact with various molecules within the cell membrane or to facilitate the movement of specific substances across it.Mutations or dysregulation of genes in the XK family can have significant implications for cell function and have been linked to various disorders. For example, mutations in the XK gene itself are known to cause McLeod syndrome, a rare, genetic, multisystem disorder. While no specific diseases have been conclusively linked to XKR6, it is plausible that it may be implicated in cellular dysfunctions or pathologies when mutated or aberrantly expressed.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+-ATPase pump, indirectly affecting membrane transport and ionic balance, which could influence processes related to XKR6. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin is a Na+/K+-ATPase inhibitor and may indirectly affect XKR6 function by altering membrane transport dynamics. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride, primarily a diuretic, inhibits sodium channels and the Na+/H+ exchanger, potentially impacting cellular processes associated with XKR6. | ||||||
Bumetanide (Ro 10-6338) | 28395-03-1 | sc-200727 sc-200727A | 1 g 5 g | $109.00 $228.00 | 9 | |
Bumetanide, a loop diuretic, inhibits the Na+-K+-2Cl− cotransporter, which could indirectly influence XKR6-related membrane transport processes. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Probenecid inhibits organic anion transporters and could affect cellular transport mechanisms, potentially impacting XKR6-related functions. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
As a calcium channel blocker, Verapamil may influence intracellular calcium dynamics, potentially affecting pathways or processes related to XKR6. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, another calcium channel blocker, could influence calcium-dependent processes and signaling pathways, potentially impacting XKR6 function. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide inhibits the Na+-K+-2Cl− cotransporter in the loop of Henle, which might indirectly affect membrane transport and signaling processes related to XKR6. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor and also affects various ion channels, potentially influencing signaling pathways and processes related to XKR6. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine, an antiarrhythmic agent, blocks voltage-gated sodium and potassium channels, potentially impacting cellular processes associated with XKR6. | ||||||